ÂÜÀòÂÒÂ×

Kate Tighe is an experienced professional in the field of public affairs and patient advocacy, currently serving as VP, Head of US Public Affairs & Patient Advocacy for Immunology and Rare Diseases at Sanofi since January 2017. At Sanofi Genzyme, Kate leads a team focused on rare disease engagement, supporting multiple therapeutic areas and advanced-stage clinical programs. Prior roles include Associate Director of Global Patient Advocacy at Sanofi Genzyme and various positions at Idera Pharmaceuticals and the Muscular Dystrophy Association. Additionally, Kate serves on the Board of Directors for Courageous Parents Network, which provides vital support for families during children's illness journeys. Kate holds a Bachelor of Arts in International Relations and Economics from Simmons University.